Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.9900
+0.0089 (0.91%)
Aug 14, 2025, 11:26 AM - Market open
Lucid Diagnostics Employees
Lucid Diagnostics had 72 employees as of December 31, 2024. The number of employees increased by 2 or 2.86% compared to the previous year.
Employees
72
Change (1Y)
2
Growth (1Y)
2.86%
Revenue / Employee
$60,556
Profits / Employee
-$941,917
Market Cap
100.87M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 72 | 2 | 2.86% |
| Dec 31, 2023 | 70 | -4 | -5.41% |
| Dec 31, 2022 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LUCD News
- 3 hours ago - PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results - PRNewsWire
- 18 hours ago - Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results - PRNewsWire
- 9 days ago - Lucid Diagnostics to Participate in Upcoming Investor Conferences - PRNewsWire
- 14 days ago - PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025 - PRNewsWire
- 15 days ago - Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 - PRNewsWire
- 15 days ago - PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule - PRNewsWire
- 4 weeks ago - MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test - PRNewsWire